Roughly six decades after the first attempt to develop a vaccine for respiratory syncytial virus, the Food and Drug Administration is poised to approve several shots by next winter.
On 27 February, World Health Organization member states will meet to commence formal negotiations on a global pandemic preparedness agreement – unofficially turning the page from responding to COVID-19 to readying ourselves for future health emergencies.
Recent Comments